COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA
Clinical trial NCT04732468 · TERMINATED
Trial details
- NCT number
- NCT04732468
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2022-07-11
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.